A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology. Callan JMB Inc. has strategic partnership with Alabama State University to advance the United States pharmaceutical manufacturing and supply chain resilience. The company was founded in 2006 and is headquartered in Spring Branch, Texas.
Financial Summary
| Share Statistics | CJMB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $14.1 | $135.2 | 8% |
|
| Shares Out (Mil) | 5.6 | 48.5 | 14% |
|
| Institutional Ownership | 16.2% | 47.2% | 8% |
|
| Float (Mil) | 2.4 | 34.5 | 6% |
|
| Beta | na | 0.95 | na |
|
| Avg Daily Volume (000s) | 714 | 184 | 64% |
|
| Price Change (52-week) |
(50.1%) | 65.9% | 14% |
|
| Growth | CJMB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.0% | na |
|
| Net Income (5yr) | na | 3.4% | na |
|
| EPS (5yr) | na | 9.9% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (7.2%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | CJMB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5 | $574 | 6% |
|
| Net Income (TTM) (Mil) | ($10) | $11 | 29% |
|
| EPS (TTM) | ($1.927) | $0.100 | 15% |
|
| Operating Cash Flow (TTM) (Mil) | ($5) | $16 | 25% |
|
| Net Cash Flow (TTM) (Mil) | ($3) | $-0 | 35% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $70 | 19% |
|
| Enterprise Value (Q1) (Mil) | na | $384 | na |
|
| Valuation | CJMB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 20.75 | 1.62 | 96% |
|
| P/E | na | 17.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.8 | na |
|
| Ratios | CJMB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 39.9% | 15.3% | 50% |
|
| Net Margin | (192.0%) | 1.4% | 5% |
|
| ROA | (145.7%) | 2.3% | 3% |
|
| ROE | (300.3%) | 5.1% | 3% |
|
| Liabilities to Assets | 84.7% | 58.7% | 78% |
|
| F-Score | 4 | 5 | 33% |
|
Callan JMB Inc. did not pass any screens on 8/21/2026.
